BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15106045)

  • 1. [Outcome of 268 patients with pancreatic carcinoma treated surgically].
    Uravic M; Depolo A; Dobrilla-Dintinjana R; Petrosic N; Grbas H; Miletic D; Tomse Z; Kastelan Z
    Zentralbl Chir; 2004 Apr; 129(2):125-9. PubMed ID: 15106045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
    Meriggi F; Gramigna P; Forni E
    Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
    Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
    Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unresectable pancreatic carcinoma: correlating length of survival with choice of palliative bypass.
    Di Fronzo LA; Cymerman J; Egrari S; O'Connell TX
    Am Surg; 1999 Oct; 65(10):955-8. PubMed ID: 10515542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
    Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
    Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.
    Kuhlmann KF; de Castro SM; Wesseling JG; ten Kate FJ; Offerhaus GJ; Busch OR; van Gulik TM; Obertop H; Gouma DJ
    Eur J Cancer; 2004 Mar; 40(4):549-58. PubMed ID: 14962722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma of the pancreas--bypass versus resection?
    Ong CL; Rauff A
    J R Coll Surg Edinb; 1993 Jun; 38(3):149-51. PubMed ID: 7687675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
    Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
    Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Palliative surgery in nonresectable pancreatic carcinoma].
    Guglielminetti D; Burgini M; Gaddoni G; Polacchini G; Fiorentini G
    G Chir; 1994 Oct; 15(10):439-42. PubMed ID: 7531479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.
    Müller MW; Friess H; Köninger J; Martin D; Wente MN; Hinz U; Ceyhan GO; Blaha P; Kleeff J; Büchler MW
    Am J Surg; 2008 Feb; 195(2):221-8. PubMed ID: 18154768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curative and palliative surgical treatment of pancreaticoduodenal adenocarcinoma.
    Hoitsma HF; Meijer S; den Otter G
    Arch Chir Neerl; 1978; 30(3):151-61. PubMed ID: 81663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.
    Smoot RL; Zhang L; Sebo TJ; Que FG
    J Am Coll Surg; 2008 Sep; 207(3):368-70. PubMed ID: 18722942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving survival following surgery for pancreatic ductal adenocarcinoma--a ten-year experience.
    Hoem D; Viste A
    Eur J Surg Oncol; 2012 Mar; 38(3):245-51. PubMed ID: 22217907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
    Gleisner AL; Assumpcao L; Cameron JL; Wolfgang CL; Choti MA; Herman JM; Schulick RD; Pawlik TM
    Cancer; 2007 Dec; 110(11):2484-92. PubMed ID: 17941009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas.
    Yang YM; Wan YL; Tian XD; Zhuang Y; Huang YT
    Chin Med J (Engl); 2005 Nov; 118(22):1863-9. PubMed ID: 16313840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oncologic risk in pylorus preservation in resection of ductal pancreas carcinoma].
    Gerdes B; Ramaswamy A; Bartsch D; Rothmund M
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1087-9. PubMed ID: 9574341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.